Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-06

FDA Approved: CARBAMAZEPINE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application for carbamazepine from Apotex Corp., granting approval for the generic product under ANDA075948. The action updates the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbamazepine (Carbamazepine)

Snippet

SUPPL AP for CARBAMAZEPINE (CARBAMAZEPINE)